Rwanda Food and Drug Authority (RFDA) have investigated and found that the four paediatric medicines that were recently found unsafe by the World Health Organisation (WHO) in The Gambia have never entered the Rwandan market.
Earlier this month, the WHO issued an alert that Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup contain “unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.”
In a communique issued on Saturday, October 8, the RFDA said it carried out local investigations in regards to the WHO’s alert, and found that the products are not on the Rwandan market.
“Rwanda FDA has checked in the import system and found that the concerned products have never entered the Rwandan market,” read part of the RFDA’s statement.
It added that the products from the manufacturer (Maiden Pharmaceuticals) are not on the lists of registered or authorised medicines in Rwanda.
“Rwanda FDA will continue the import control and surveillance on the market,” the statement read, before calling upon the public to report any suspected quality or safety issue on any medicines.
